Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Molecular Hepatology"
DOI: 10.3350/cmh.2022.0082
Abstract: Background/Aims Studies of hepatic steatosis (HS) effect on COVID-19 vaccine immunogenicity are lacking. We aimed to compare immunogenicity of BNT162b2 and CoronaVac among moderate/severe HS and control subjects. Methods Two hundred ninety-five subjects who received… read more here.
Keywords: bnt162b2 coronavac; moderate severe; hepatic steatosis; response ... See more keywords